Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jul 07, 2016 $86.58 $90.20 $86.14 $88.16 6 732 200
Jul 06, 2016 $80.34 $81.13 $77.98 $80.81 1 402 500
Jul 05, 2016 $80.64 $80.69 $79.23 $79.86 1 353 900
Jul 01, 2016 $77.59 $81.67 $77.04 $81.38 1 651 500
Jun 30, 2016 $78.71 $79.85 $76.27 $77.80 1 853 500
Jun 29, 2016 $80.52 $81.08 $78.20 $78.37 2 142 100
Jun 28, 2016 $76.23 $79.71 $76.02 $79.49 1 585 100
Jun 27, 2016 $75.87 $77.01 $73.45 $74.61 2 023 000
Jun 24, 2016 $79.56 $83.40 $76.76 $77.01 2 572 500
Jun 23, 2016 $82.87 $83.83 $81.70 $83.65 1 398 800
Jun 22, 2016 $80.81 $83.98 $80.34 $82.18 1 233 500
Jun 21, 2016 $84.05 $84.05 $80.55 $81.22 1 427 900
Jun 20, 2016 $82.77 $85.80 $82.76 $84.06 1 682 200
Jun 17, 2016 $84.30 $84.97 $82.01 $83.86 3 994 700
Jun 16, 2016 $83.19 $84.50 $78.16 $80.80 3 145 655
Jun 15, 2016 $81.40 $85.53 $81.31 $84.01 1 906 419
Jun 14, 2016 $80.22 $82.66 $79.55 $81.05 1 139 954
Jun 13, 2016 $81.09 $83.98 $79.50 $80.11 1 253 187
Jun 10, 2016 $82.35 $82.48 $79.52 $81.10 1 080 173
Jun 09, 2016 $83.75 $84.61 $82.71 $82.94 891 547
Jun 08, 2016 $85.36 $85.64 $83.04 $84.10 1 021 090
Jun 07, 2016 $88.64 $89.30 $85.23 $85.50 1 178 323
Jun 06, 2016 $89.14 $90.05 $87.21 $89.52 721 862
Jun 03, 2016 $91.15 $91.49 $88.02 $90.00 1 107 650
Jun 02, 2016 $87.17 $92.48 $87.17 $91.52 1 950 583
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT